14-day Premium Trial Subscription Sign Up For FreeGet Free

Akebia Therapeutics Stock Price (Quote) NASDAQ:AKBA

$2.90 ( 2.84% ) Friday, 17th Sep 2021

Range Low Price High Price Comment
30 days $2.35 $3.15 Friday, 17th Sep 2021 AKBA stock ended at $2.90. This is 2.84% more than the trading day before Thursday, 16th Sep 2021. During the day the stock fluctuated 6.59% from a day low at $2.73 to a day high of $2.91.
90 days $2.35 $4.33
52 weeks $2.09 $5.14

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
2021-09-17 $2.81 $2.91 $2.73 $2.90 4 996 384
2021-09-16 $2.76 $2.83 $2.70 $2.82 1 099 260
2021-09-15 $2.77 $2.83 $2.72 $2.78 1 459 776
2021-09-14 $2.92 $2.95 $2.75 $2.75 1 966 533
2021-09-13 $2.88 $3.00 $2.84 $2.92 1 873 446
2021-09-10 $3.02 $3.02 $2.88 $2.88 1 321 506
2021-09-09 $2.97 $3.06 $2.93 $2.95 1 793 185
2021-09-08 $3.01 $3.03 $2.89 $2.94 1 638 700
2021-09-07 $3.05 $3.13 $2.95 $2.98 1 429 109
2021-09-03 $3.09 $3.10 $2.95 $3.03 2 755 959
2021-09-02 $3.06 $3.15 $3.01 $3.14 3 134 904
2021-09-01 $2.92 $3.07 $2.92 $3.05 2 753 125
2021-08-31 $2.83 $2.99 $2.82 $2.94 2 445 756
2021-08-30 $2.79 $2.90 $2.78 $2.82 1 977 478
2021-08-27 $2.65 $2.87 $2.62 $2.85 3 668 200
2021-08-26 $2.68 $2.77 $2.60 $2.61 1 610 311
2021-08-25 $2.63 $2.74 $2.57 $2.68 1 615 271
2021-08-24 $2.70 $2.74 $2.57 $2.61 1 545 710
2021-08-23 $2.56 $2.69 $2.51 $2.66 2 294 637
2021-08-20 $2.36 $2.52 $2.36 $2.51 2 306 377
2021-08-19 $2.43 $2.49 $2.35 $2.35 3 213 542
2021-08-18 $2.56 $2.58 $2.41 $2.43 2 969 203
2021-08-17 $2.41 $2.56 $2.40 $2.56 1 925 989
2021-08-16 $2.50 $2.52 $2.43 $2.43 2 351 640
2021-08-13 $2.63 $2.64 $2.51 $2.52 1 750 178
2021-08-12 $2.62 $2.66 $2.54 $2.63 1 795 482
2021-08-11 $2.69 $2.73 $2.53 $2.57 3 692 693
2021-08-10 $2.77 $2.77 $2.61 $2.64 3 401 066
2021-08-09 $2.76 $2.82 $2.70 $2.73 4 473 875
2021-08-06 $2.78 $2.87 $2.72 $2.74 3 797 933
2021-08-05 $2.41 $2.87 $2.41 $2.87 5 737 253
2021-08-04 $2.54 $2.66 $2.48 $2.48 2 614 128
2021-08-03 $2.61 $2.64 $2.49 $2.57 2 041 248
2021-08-02 $2.50 $2.63 $2.46 $2.60 1 809 698
2021-07-30 $2.54 $2.58 $2.45 $2.47 2 004 320
2021-07-29 $2.63 $2.68 $2.52 $2.52 2 447 196
2021-07-28 $2.54 $2.64 $2.51 $2.64 2 944 841
2021-07-27 $2.47 $2.58 $2.36 $2.53 4 983 045
2021-07-26 $2.48 $2.56 $2.43 $2.47 5 006 327
2021-07-23 $2.60 $2.61 $2.47 $2.47 6 160 703
2021-07-22 $2.74 $2.74 $2.55 $2.55 7 233 154
2021-07-21 $2.68 $2.78 $2.57 $2.70 12 528 119
2021-07-20 $2.90 $2.93 $2.66 $2.67 11 360 695
2021-07-19 $3.03 $3.04 $2.84 $2.88 6 747 332
2021-07-16 $3.47 $3.47 $3.10 $3.10 7 023 865
2021-07-15 $3.50 $3.60 $3.31 $3.32 3 086 803
2021-07-14 $3.33 $3.63 $3.32 $3.54 8 690 099
2021-07-13 $3.31 $3.36 $3.26 $3.33 2 925 877
2021-07-12 $3.41 $3.44 $3.27 $3.34 3 248 958
2021-07-09 $3.41 $3.43 $3.33 $3.41 1 123 454

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is vadadustat, an oral therapy which has completed a Phase II study for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients; and clinical product candidate is ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT